Systematic review on the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in the long-term management of treatment-resistant depression
作者
Letícia da Fonte Porto Carreiro de Paula,Guilherme Barros Vieira de Mello,Cecília Avellar Diniz Rebêlo Távora,Paulo de Morais Andrade Lima Neto,Vinícius Ramos Ribeiro,Beatriz Serpa Vieira,Paulo André Jordão de Paiva Serpa,Hanna Nathália Antunes de Souza,Philippe Villas Boas Duarte,Julianna Cristhina Bezerra Cardoso,José Petrúcio de Siqueira Neto,Fernando Vieira de Paiva Borges,Luana Tamiozzo Arraes,Ramon Cabral Rodrigues,João Guilherme Nogueira Veloso Carvalho
Treatment-resistant depression (TRD) poses a significant clinical challenge, as many patients fail to respond to conventional antidepressants. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising alternative for resistant cases by targeting brain regions involved in mood regulation. This systematic review aims to evaluate the efficacy and safety of rTMS compared to electroconvulsive therapy (ECT), assess the durability of its antidepressant effects, and explore its applicability in specific populations. Studies were identified in the BVS, SciELO, and PubMed databases using the terms "Repetitive Transcranial Magnetic Stimulation," "Depression," and "Safety." Inclusion criteria encompassed randomized controlled trials, cohort studies, and systematic reviews addressing the efficacy and safety of rTMS in TRD. The findings indicate that rTMS offers significant antidepressant benefits for non-psychotic TRD, with lower dropout rates and fewer cognitive side effects compared to ECT. However, without maintenance protocols, its initial efficacy diminishes over time. Response rates reached 66.5% after three months but declined to 46.3% after one year, emphasizing the importance of maintenance strategies. While rTMS shows reduced effectiveness in severe conditions, such as psychotic depression, its higher patient acceptance and lower cognitive burden position it as an attractive option. Future research should focus on long-term maintenance strategies, particularly in adolescents and patients with comorbidities.